Ricardo Correa‐Rotter
Researcher Next ID · RN-010156
Researcher · Medicine
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
, Mexico
- Works count
- 314
- Citation count
- 19,792
- H-index
- 54
- i10-index
- 142
Research interests
Publications
Dapagliflozin in Patients with Chronic Kidney Disease
New England Journal of Medicine · 2020 · 10.1056/nejmoa2024816
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
The Lancet Diabetes & Endocrinology · 2020 · 10.1016/s2213-8587(20)30369-7
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
The Lancet · 2017 · 10.1016/s0140-6736(17)30788-2
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
The Lancet · 2013 · 10.1016/s0140-6736(13)60595-4
Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis
Journal of the American Society of Nephrology · 2002 · 10.1681/asn.v1351307
Current projects
No projects listed.